Hydrochloric Acid → HCID 135856758, compound
Reaction equation
[CH2:1]([O:3][C:4]1[CH:9]=[CH:8][C:7]([S:10]([N:13]2[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][OH:21])[CH2:15][CH2:14]2)(=[O:12])=[O:11])=[CH:6][C:5]=1[C:22]1[NH:27][C:26](=[O:28])[C:25]2=[C:29]([CH3:35])[N:30]=[C:31]([CH2:32][CH2:33][CH3:34])[N:24]2[N:23]=1)[CH3:2].[ClH:36]>CCOCC>[ClH:36].[CH2:1]([O:3][C:4]1[CH:9]=[CH:8][C:7]([S:10]([N:13]2[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][OH:21])[CH2:15][CH2:14]2)(=[O:12])=[O:11])=[CH:6][C:5]=1[C:22]1[NH:27][C:26](=[O:28])[C:25]2=[C:29]([CH3:35])[N:30]=[C:31]([CH2:32][CH2:33][CH3:34])[N:24]2[N:23]=1)[CH3:2]Participants
4
Procedure
200 mg (0.39 mmol) of 2-{2-ethoxy-5-[4-(2-hydroxy-ethyl)-piperazine-1-sulphonyl]-phenyl}-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one are suspended in ether, admixed with 2 ml of a 1M solution of HCl in ether and stirred at room temperature for 20 minutes. The solvent is removed, giving 209 mg (100%) of 2-{2-ethoxy-5-[4-(2-hydroxy-ethyl)-piperazine-1-sulphonyl]-phenyl}-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one hydrochloride.
Workup
- customThe solvent is removed
Sources & evidence
- ORD record
- ord-1e171af5eaaf4a6983ff537fdf83afc1
- Source dataset
- uspto-grants-2008_01
- Patent number
- US07314871B2
Reaction notes
Loading…